The purpose of the Center for Medicinal Cannabis Research is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions.

news

 

CMCR recipient of Major Philanthropic Award

Autism is a complex neurodevelopmental disorder that affects an estimated 1 in 68 children in the United States, yet treatment options are limited. Could cannabidiol (CBD), a non-psychoactive compound found in cannabis, hold clues for developing effective therapies? Thanks to a major gift from the Ray and Tye Noorda Foundation, researchers at the University of California San Diego will embark on a multidisciplinary study to investigate the potential of cannabidiol as a treatment for severe autism. The award was given in partnership with and based on recommendations the Noorda Foundation received from the Wholistic Research and Education Foundation.

The $4.7 million gift to the Center for Medicinal Cannabis Research (CMCR) at UC San Diego School of Medicine is the largest private gift to date for medicinal cannabis research in the United States. The funding will support translational research to investigate whether medicinal cannabinoid therapies can alleviate symptoms in children with severe autism—and if so, how. The groundbreaking study spans clinical, basic science, advanced mathematics and genetic techniques across the same cohort of patients, offering a comprehensive and systematic exploration of CBD efficacy on autism.

Read the full release

Click here for more information about the study


Medical Marijuana a Hit With Seniors

Serena Gordon, HealthDay, July 5, 2018

Seniors are giving rave reviews for medical marijuana.

In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers.

Nine out of 10 liked it so much they said they'd recommend medical pot to others.

"I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you," said one senior.

Another patient put it this way: "It [medical marijuana] is extremely effective and has allowed me to function in my work and life again. It has not completely taken away the pain, but allows me to manage it."

Read the article here


First marijuana-derived drug is on the verge of approval

Laurie McGinley, The Washington Post, June 23, 2018

At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For almost two decades, her desperate parents tried drug after drug to treat her rare type of childhood epilepsy, but the medications mostly produced side effects — pancreatitis, hives and extreme drowsiness — and she was frequently hospitalized. Family outings became almost impossible. Eventually, her mother said, Marissa stopped smiling.

Three years ago, Marissa was enrolled in a clinical trial at Nationwide Children's Hospital in Columbus, Ohio, testing a liquid anti-seizure drug made from a component of marijuana. Marissa, who cannot speak and uses a wheelchair, quickly went from eight seizures a day to half that number; these days, the 21-year-old has some weeks in which she doesn't have any seizures. She routinely goes to her sisters' baseball games and band concerts. In 2016, she and her family visited Mount Rushmore and the Grand Canyon. Plus, she's smiling again.

Read the article here


CMCR featured in Voice of San Diego Podcast

Voice of San Diego, June 15, 2018

In the second half of the show, UC San Diego professor Thomas Marcotte talks with Marx about his cannabis research, including a study looking at the effects of marijuana on driving.

Listen to the podcast (Interview with Dr. Marcotte begins at 30:22)


More News

Click here to access the CMCR news archives.

Igor Grant, MD

Introduction/Overview
CMCR Symposium, June 2018


Ziva Cooper, PhD

Therapeutic potential of cannabis for pain alone and as an adjunct to opioids
CMCR Symposium, June 2018


Iain McGregor, PhD

Medicinal cannabis research down under: Introducing the Lambert Initiative for Cannabinoid Therapeutics
CMCR Symposium, June 2018


Thomas Marcotte, PhD

Cannabis and public safety: The challenge of cannabis-impaired driving
CMCR Symposium, June 2018


Alan Budney, PhD

Medicinal cannabis / legalization and the development of cannabis use problems
CMCR Symposium, June 2018


Copyright © 2018 CENTER FOR MEDICINAL CANNABIS RESEARCH. | University of California, San Diego
cmcr@ucsd.edu | HNRP |